192 related articles for article (PubMed ID: 12638473)
1. [New anticoagulants -- their clinical significance].
Haas S
Ther Umsch; 2003 Jan; 60(1):19-23. PubMed ID: 12638473
[TBL] [Abstract][Full Text] [Related]
2. [The new antithrombotic agents].
Meyer Samama M
Presse Med; 2005 Oct; 34(18):1309-14. PubMed ID: 16269995
[TBL] [Abstract][Full Text] [Related]
3. [Treatment and prevention of venous thromboembolic events: present and future antithrombotic agents].
Drouet L
Bull Acad Natl Med; 2003; 187(1):85-96; discussion 96-7. PubMed ID: 14556456
[TBL] [Abstract][Full Text] [Related]
4. [The first oral thrombin inhibitor. Competition to heparins and marcumar?].
MMW Fortschr Med; 2003 Mar; 145(10):56. PubMed ID: 12688030
[No Abstract] [Full Text] [Related]
5. Orally active direct thrombin inhibitors.
Weitz J
Semin Vasc Med; 2003 May; 3(2):131-8. PubMed ID: 15199476
[TBL] [Abstract][Full Text] [Related]
6. [Melagatran and ximelagatran. Pharmacologic characteristics and anesthesiological aspects].
Pindur G; Ziegeler S; Kleinschmidt S
Anaesthesist; 2003 Dec; 52(12):1171-5. PubMed ID: 14691631
[TBL] [Abstract][Full Text] [Related]
7. A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I. MElagatran for THRombin inhibition in Orthopaedic surgery.
Eriksson BI; Arfwidsson AC; Frison L; Eriksson UG; Bylock A; Kälebo P; Fager G; Gustafsson D
Thromb Haemost; 2002 Feb; 87(2):231-7. PubMed ID: 11858482
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.
Halperin JL
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):163-74. PubMed ID: 15151465
[TBL] [Abstract][Full Text] [Related]
9. Oral direct thrombin inhibitors in clinical development.
Gustafsson D
J Intern Med; 2003 Oct; 254(4):322-34. PubMed ID: 12974871
[TBL] [Abstract][Full Text] [Related]
10. Treating thrombosis in the 21st century.
Shapiro SS
N Engl J Med; 2003 Oct; 349(18):1762-4. PubMed ID: 14585945
[No Abstract] [Full Text] [Related]
11. Clinical trials of new anticoagulants.
Anderson J; O'Donnell M
Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
[TBL] [Abstract][Full Text] [Related]
12. [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
Nielsen JD
Ugeskr Laeger; 2005 May; 167(21):2261-5. PubMed ID: 15962850
[No Abstract] [Full Text] [Related]
13. Beyond unfractionated heparin and warfarin: current and future advances.
Hirsh J; O'Donnell M; Eikelboom JW
Circulation; 2007 Jul; 116(5):552-60. PubMed ID: 17664384
[No Abstract] [Full Text] [Related]
14. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
Andersen JC
Semin Thromb Hemost; 2004 Dec; 30(6):609-18. PubMed ID: 15630666
[TBL] [Abstract][Full Text] [Related]
15. [Prevention and treatment of deep vein thrombosis with ximelagatran].
Caspary L; Bauersachs R; Brehme S; Creutzig A; Harenberg J; Hoffmann U; Landgraf H; Schellong S
Dtsch Med Wochenschr; 2004 Jul; 129(30):1635-40. PubMed ID: 15257504
[No Abstract] [Full Text] [Related]
16. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
[TBL] [Abstract][Full Text] [Related]
17. Two new antithrombotic agents (fondaparinux and ximelagatran) and their implications in anesthesia.
de Moerloose P; Boehlen F
Can J Anaesth; 2002; 49(6):S5-10. PubMed ID: 12557410
[TBL] [Abstract][Full Text] [Related]
18. [Prophylaxis and treatment of venous thromboembolism: the role of new antithrombotic drugs].
Falciani M; Imberti D; Prisco D
Recenti Prog Med; 2005 Apr; 96(4):196-204. PubMed ID: 15932039
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic effects of ximelagatran plus acetylsalicylic acid (ASA) and clopidogrel plus ASA in a human ex vivo arterial thrombosis model.
Wåhlander K; Eriksson-Lepkowska M; Nyström P; Eriksson UG; Sarich TC; Badimon JJ; Kalies I; Elg M; Bylock A
Thromb Haemost; 2006 Mar; 95(3):447-53. PubMed ID: 16525572
[TBL] [Abstract][Full Text] [Related]
20. [New antithrombotic drugs: fondaparinux, idraparinux, ximelagatran].
Rewiuk K; Franczuk P; Grodzicki T
Przegl Lek; 2005; 62(8):799-803. PubMed ID: 16521501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
